Civil society involvement in harm reduction drug policy: reflections on the past, expectations for the future
Abstract Background A range of civil society organisations (CSOs) such as drug user groups, non-governmental/third sector organisations and networks of existing organisations, seek to shape the development of drugs policy at national and international levels. However, their capacity to do so is shap...
Saved in:
Main Authors: | Aileen O'Gorman (Author), Eberhard Schatz (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harm reduction in Europe: a framework for civil society-led monitoring
by: Rafaela Rigoni, et al.
Published: (2021) -
The Concept of Harm Reduction from Tobacco: Past, Present, Future
by: S. L. Babak, et al.
Published: (2021) -
Drug use, homelessness and health: responding to the opioid overdose crisis with housing and harm reduction services
by: Katrina Milaney, et al.
Published: (2021) -
Protecting the Public's Health in Pandemics: Reflections on Policy Deliberation and the Role of Civil Society in Democracy
by: Mary Beth Quaranta Morrissey, et al.
Published: (2021) -
Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
by: Juan M. Pericàs, et al.
Published: (2019)